Robb Gary Charles — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Robb Gary Charles has filed 3 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.22M.

Profile

Robb Gary Charles

Gary Charles Robb is the Chief Business Officer at Corcept Therapeutics Inc, a pharmaceutical company focused on developing treatments for disorders related to cortisol. He has been involved in multiple SEC filings related to his role at the company.

RoleInsider
Notability20/100

Board memberships

Awards & honors

Recent Transactions

DateTickerCompanyCodeSharesPriceValue
2026-07-09CORTCORCEPT THERAPEUTICS INCG — Bona-fide gift600$0.00
2026-06-03CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture358$70.44$25K
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award776$0.00
2026-06-03CORTCORCEPT THERAPEUTICS INCA — Grant or award776$70.44$55K
2026-05-15CORTCORCEPT THERAPEUTICS INCG — Bona-fide gift1.0K$0.00
2026-05-15CORTCORCEPT THERAPEUTICS INCG — Bona-fide gift1.0K$0.00
2026-05-15CORTCORCEPT THERAPEUTICS INCG — Bona-fide gift5.3K$0.00
2026-03-05CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture121$35.97$4K
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award499$0.00
2026-03-05CORTCORCEPT THERAPEUTICS INCA — Grant or award499$35.97$18K
2025-12-29CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture80.3K$83.59$6.71M
2025-12-29CORTCORCEPT THERAPEUTICS INCM — Option exercise145.0K$3.88$563K
2025-12-04CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture148$79.78$12K
2025-12-04CORTCORCEPT THERAPEUTICS INCA — Grant or award224$0.00
2025-12-04CORTCORCEPT THERAPEUTICS INCA — Grant or award224$79.78$18K
2025-09-02CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture256$71.38$18K
2025-09-02CORTCORCEPT THERAPEUTICS INCA — Grant or award251$0.00
2025-09-02CORTCORCEPT THERAPEUTICS INCA — Grant or award251$71.38$18K
2025-08-22CORTCORCEPT THERAPEUTICS INCF — Tax withholding / forfeiture2.7K$71.17$190K
2025-08-22CORTCORCEPT THERAPEUTICS INCS — Open-market sale2.3K$71.27$166K

Companies — Last 90 Days

Frequently Asked Questions

Who is Robb Gary Charles?

Gary Charles Robb is the Chief Business Officer at Corcept Therapeutics Inc, a pharmaceutical company focused on developing treatments for disorders related to cortisol. He has been involved in multiple SEC filings related to his role at the company.…

How many SEC Form 4 filings has Robb Gary Charles submitted recently?

3 primary Form 4 filings in the last 90 days, covering 1 company.

Has Robb Gary Charles been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 5 open-market sales ($1.22M) across all tracked filings.

Where can I see all of Robb Gary Charles's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

Open the live Robb Gary Charles profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.